
Willxone-S 750 Injection
Marketer
Alvoncare Pharma
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Willxone-S 750 Injection
Infectil 750 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation and infection spread. Administration must be solely under a physician's direction. Consistent adherence to the prescribed dosage schedule is crucial; complete the full course, regardless of symptom improvement. Premature cessation may compromise treatment efficacy. Nausea, vomiting, diarrhea, and dyspepsia are potential side effects; escalating symptoms warrant immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor before initiating treatment. Pregnant or lactating individuals should consult their physician. Alcohol consumption should be avoided due to potential synergistic drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing somnolence or vertigo. Adequate rest, balanced nutrition, and hydration accelerate recovery. Your physician may order lab tests to monitor the drug's efficacy.
Uses of Willxone-S 750 Injection
Infections caused by bacteria
Major Benefits of Willxone-S 750 Injection:
Administering this medication will be performed by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Willxone-S 750 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Willxone-S 750 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Willxone-S 750 Injection works:
Ceftriaxone and Sulbactam, the components of Willxone-S 750 Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus improving Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Willxone-S 750 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injection Willxone-S 750 is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; clinical data in humans, however, remain scarce.
Breast feedingCAUTION
The administration of Willxone-S 750 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Willxone-S 750 Injection might induce drowsiness, blurred vision, or dizziness. Operation of vehicles is contraindicated if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Willxone-S 750 Injection use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
For patients experiencing severe hepatic impairment, Willxone-S 750 Injection requires careful administration and potential dosage modification. A physician's consultation is advised. Dosage alteration for Willxone-S 750 Injection is unnecessary in individuals with mild or moderate liver dysfunction.
What if you forget to take Willxone-S 750 Injection :
Should you forget a Willxone-S 750 Injection, seek medical advice.
Facts to Know About Willxone-S 750 Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Antimicrobial agents |
